Short course radiation for intermediate-risk head and neck cancer
Part of Cancer clinical trials.
This trial tests a shorter course of radiation for people with intermediate-risk head and neck cancer after surgery. It aims to reduce side effects while keeping treatment effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You had surgery to remove head and neck cancer, and the surgery removed all visible cancer with clear edges
- Your pathology report shows at least one 'intermediate-risk' feature (like close margins, certain tumor or node stage, or cancer in nerves or vessels)
- You are in generally good health (able to perform daily activities) and have adequate blood counts
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests a specific, shorter type of focused radiation to help relieve symptoms from head and neck squamous cell carcinoma. It compares two radiation timing/planning approaches to see which better improves comfort and quality of life.
This trial tests whether giving a slightly different schedule of radiation (more frequent, smaller doses) can improve treatment for people with large head and neck cancers. It is for patients who are getting radiation as their main treatment, sometimes with chemotherapy as well.
This trial looks at whether giving less (de-escalated) radiation after surgery is as effective and safer for people with locally advanced head and neck squamous cell carcinoma who had a strong response to treatment before surgery. If you had no remaining cancer or only very small amounts of cancer left in the surgical specimen, this approach may help reduce side effects while keeping control of the disease.
This trial tests a shorter course of radiation therapy for patients aged 65 and older with head and neck cancer who cannot have surgery or standard radiation. The goal is to find an effective and more convenient treatment option.
This trial tests a shorter course of radiation therapy for people with nasopharyngeal cancer, a type of head and neck cancer. The goal is to see if a hypofractionated (fewer, larger doses) approach is safe and effective.
This trial compares two ways of giving radiation therapy for head and neck cancers that haven't spread. It aims to see which approach gives patients a better quality of life. If you are planning curative treatment, this study may help you and your doctor choose the best radiation schedule.
Hear when a new Head and Neck Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.